000 02388 a2200661 4500
005 20250517205528.0
264 0 _c20180924
008 201809s 0 0 eng d
022 _a1476-0711
024 7 _a10.1186/s12941-018-0267-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPang, Feng
245 0 0 _aFactors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
_h[electronic resource]
260 _bAnnals of clinical microbiology and antimicrobials
_cMar 2018
300 _a13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBacteremia
_xdrug therapy
650 0 4 _aBiliary Tract Diseases
_xdrug therapy
650 0 4 _aBody Fluids
_xmicrobiology
650 0 4 _aCarbapenem-Resistant Enterobacteriaceae
_xdrug effects
650 0 4 _aChina
650 0 4 _aCross Infection
_xdrug therapy
650 0 4 _aDrug Resistance, Multiple, Bacterial
_xdrug effects
650 0 4 _aEnterobacter cloacae
_xpathogenicity
650 0 4 _aEnterobacteriaceae
_xdrug effects
650 0 4 _aEnterobacteriaceae Infections
_xdrug therapy
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHospitalization
650 0 4 _aHospitals
650 0 4 _aHumans
650 0 4 _aIntensive Care Units
650 0 4 _aKlebsiella oxytoca
_xdrug effects
650 0 4 _aKlebsiella pneumoniae
_xpathogenicity
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPneumonia
_xdrug therapy
650 0 4 _aPneumonia, Ventilator-Associated
_xdrug therapy
650 0 4 _aPrevalence
650 0 4 _aPyelonephritis
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSepsis
_xdrug therapy
650 0 4 _aTertiary Care Centers
650 0 4 _aTreatment Outcome
650 0 4 _aUrinary Tract Infections
_xdrug therapy
650 0 4 _aWound Infection
_xdrug therapy
650 0 4 _aYoung Adult
700 1 _aJia, Xiu-Qin
700 1 _aZhao, Qi-Gang
700 1 _aZhang, Yi
773 0 _tAnnals of clinical microbiology and antimicrobials
_gvol. 17
_gno. 1
_gp. 13
856 4 0 _uhttps://doi.org/10.1186/s12941-018-0267-8
_zAvailable from publisher's website
999 _c28210312
_d28210312